1. The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts
    Mohamad Assi et al, 2016, Oxidative Medicine and Cellular Longevity CrossRef
  2. Mitophagy in Cancer: A Tale of Adaptation
    Monica Vara-Perez et al, 2019, Cells CrossRef
  3. Combined administration of lauric acid and glucose improved cancer‐derived cardiac atrophy in a mouse cachexia model
    Shota Nukaga et al, 2020, Cancer Science CrossRef
  4. Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism
    Fabrizio Pin et al, 2019, Journal of Cachexia, Sarcopenia and Muscle CrossRef
  5. Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue
    Joseph Bohlen et al, 2018, Journal of Cachexia, Sarcopenia and Muscle CrossRef
  6. Exercise training counteracts urothelial carcinoma-induced alterations in skeletal muscle mitochondria phospholipidome in an animal model
    Javier-Fernando Montero-Bullon et al, 2019, Scientific Reports CrossRef
  7. ER Stress and Unfolded Protein Response in Cancer Cachexia
    Anirban Roy et al, 2019, Cancers CrossRef
  8. Molecular Basis for the Therapeutic Effects of Exercise on Mitochondrial Defects
    Jonathan M. Memme et al, 2021, Frontiers in Physiology CrossRef
  9. The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting
    James A. Carson et al, 2016, Seminars in Cell & Developmental Biology CrossRef
  10. Tumor-derived cytokines impair myogenesis and alter the skeletal muscle immune microenvironment
    Kelly A. Hogan et al, 2018, Cytokine CrossRef
  11. The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting
    Derek T Hall et al, 2018, EMBO Molecular Medicine CrossRef
  12. Evaluation of cancer-derived myocardial impairments using a mouse model
    Yoshihiro Miyagawa et al, 2020, Oncotarget CrossRef
  13. Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content
    Daria Neyroud et al, 2019, Journal of Muscle Research and Cell Motility CrossRef
  14. The pathogenesis and treatment of cardiac atrophy in cancer cachexia
    Kate T. Murphy, 2016, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
  15. Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2/TRIP15/ALIEN
    Christiano R.R. Alves et al, 2020, Molecular Metabolism CrossRef
  16. Repeated eccentric contractions positively regulate muscle oxidative metabolism and protein synthesis during cancer cachexia in mice
    Justin P. Hardee et al, 2020, Journal of Applied Physiology CrossRef
  17. The High Costs of Low-Grade Inflammation: Persistent Fatigue as a Consequence of Reduced Cellular-Energy Availability and Non-adaptive Energy Expenditure
    Tamara E. Lacourt et al, 2018, Frontiers in Behavioral Neuroscience CrossRef
  18. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade
    Juulia H. Lautaoja et al, 2019, American Journal of Physiology-Endocrinology and Metabolism CrossRef
  19. Tissue-specific dysregulation of mitochondrial respiratory capacity and coupling control in colon-26 tumor-induced cachexia
    Jessica L. Halle et al, 2019, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology CrossRef
  20. Mediators of cachexia in cancer patients
    Josep M. Argilés et al, 2019, Nutrition CrossRef
  21. Muscle wasting in cancer
    Josep M. Argilés et al, 2015, Current Opinion in Clinical Nutrition and Metabolic Care CrossRef
  22. Mitochondrial Metabolism in Cancer Cachexia: Novel Drug Target
    Dhwani T. Dave et al, 2020, Current Drug Metabolism CrossRef
  23. The 2015 ESPEN Sir David Cuthbertson lecture: Inflammation as the driving force of muscle wasting in cancer
    Josep M. Argilés, 2017, Clinical Nutrition CrossRef
  24. Cancer cachexia: understanding the molecular basis
    Josep M. Argilés et al, 2014, Nature Reviews Cancer CrossRef
  25. Cachexia and sarcopenia: mechanisms and potential targets for intervention
    Josep M Argilés et al, 2015, Current Opinion in Pharmacology CrossRef
  26. Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting
    Hawley E. Kunz et al, 2020, Journal of Biological Chemistry CrossRef
  27. Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes
    Julie B. McLean et al, 2014, Frontiers in Physiology CrossRef
  28. Development and progression of cancer cachexia: Perspectives from bench to bedside
    Seongkyun Lim et al, 2020, Sports Medicine and Health Science CrossRef
  29. Disease-associated metabolic alterations that impact satellite cells and muscle regeneration: perspectives and therapeutic outlook
    Josiane Joseph et al, 2021, Nutrition & Metabolism CrossRef
  30. Novel investigational drugs mimicking exercise for the treatment of cachexia
    F. Penna et al, 2016, Expert Opinion on Investigational Drugs CrossRef
  31. Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies
    Agnès Martin et al, 2021, Journal of Cachexia, Sarcopenia and Muscle CrossRef
  32. Phosphorylation of Dynamin-Related Protein 1 (DRP1) Regulates Mitochondrial Dynamics and Skeletal Muscle Wasting in Cancer Cachexia
    Xiangyu Mao et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  33. Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia
    Michaela Schäfer et al, 2016, Molecular Metabolism CrossRef
  34. The Etiology and Impact of Muscle Wasting in Metastatic Cancer
    Anup K. Biswas et al, 2020, Cold Spring Harbor Perspectives in Medicine CrossRef
  35. Inflammatory signalling regulates eccentric contraction-induced protein synthesis in cachectic skeletal muscle
    Justin P. Hardee et al, 2018, Journal of Cachexia, Sarcopenia and Muscle CrossRef
  36. Modulating Metabolism to Improve Cancer-Induced Muscle Wasting
    Fabio Penna et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
  37. Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia
    Celine M. Op den Kamp et al, 2015, Journal of Cachexia, Sarcopenia and Muscle CrossRef
  38. The Skeletal Muscle as an Active Player Against Cancer Cachexia
    Fabio Penna et al, 2019, Frontiers in Physiology CrossRef
  39. The Redox Balance: A Target for Interventions Against Muscle Wasting in Cancer Cachexia?
    Fabio Penna et al, 2020, Antioxidants & Redox Signaling CrossRef
  40. Mitochondrial dynamics in cancer-induced cachexia
    Miranda van der Ende et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  41. Mitochondrial plasticity in cancer-related muscle wasting
    Rui Vitorino et al, 2015, Current Opinion in Clinical Nutrition and Metabolic Care CrossRef
  42. Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation
    Brandon N. VanderVeen et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
  43. Pharmacological or genetic inhibition of iNOS prevents cachexia‐mediated muscle wasting and its associated metabolism defects
    Jason Sadek et al, 2021, EMBO Molecular Medicine CrossRef
  44. 13C MRS and LC–MS Flux Analysis of Tumor Intermediary Metabolism
    Alexander A. Shestov et al, 2016, Frontiers in Oncology CrossRef
  45. Aerobic exercise training as therapy for cardiac and cancer cachexia
    Christiano Robles Rodrigues Alves et al, 2015, Life Sciences CrossRef
  46. Metabolism and Skeletal Muscle Homeostasis in Lung Disease
    Ermelinda Ceco et al, 2017, American Journal of Respiratory Cell and Molecular Biology CrossRef
  47. Exosomal microRNAs in cancer-related sarcopenia: Tumor-derived exosomal microRNAs in muscle atrophy
    Chenyuan Li et al, 2021, Experimental Biology and Medicine CrossRef
  48. Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism
    Justin P. Hardee et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
  49. PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia
    Fabrizio Pin et al, 2019, The FASEB Journal CrossRef
  50. Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia
    null O’Connell et al, 2019, Cancers CrossRef
  51. Muscle Stem Cell-Derived Extracellular Vesicles Reverse Hydrogen Peroxide-Induced Mitochondrial Dysfunction in Mouse Myotubes
    Kyle T. Shuler et al, 2020, Cells CrossRef
  52. Assessing Metabolic Dysregulation in Muscle During Cachexia
    Myriam Y. Hsu et al, 2019, Cancer Metabolism CrossRef
  53. Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations
    Fabrizio Pin et al, 2015, Oncotarget CrossRef
  54. Discerning Primary and Secondary Factors Responsible for Clinical Fatigue in Multisystem Diseases
    David Maughan et al, 2014, Biology CrossRef
  55. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype
    Alba Chacon-Cabrera et al, 2017, Journal of Cellular Physiology CrossRef
  56. Muscle alterations in the development and progression of cancer-induced muscle atrophy: a review
    Megan E. Rosa-Caldwell et al, 2020, Journal of Applied Physiology CrossRef
  57. Understanding cachexia as a cancer metabolism syndrome
    P E Porporato, 2016, Oncogenesis CrossRef
  58. Metabolic Remodeling in Skeletal Muscle Atrophy as a Therapeutic Target
    Alessandra Renzini et al, 2021, Metabolites CrossRef
  59. Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression
    Angie M. Y. Shum et al, 2018, Oncotarget CrossRef
  60. The wasting‐associated metabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration
    Paige C. Arneson‐Wissink et al, 2020, JCSM Rapid Communications CrossRef
  61. A Metabolic Change towards Fermentation Drives Cancer Cachexia in Myotubes
    Michele Mannelli et al, 2021, Biomedicines CrossRef
  62. Skeletal Muscle Deconditioning in Breast Cancer Patients Undergoing Chemotherapy: Current Knowledge and Insights From Other Cancers
    Joris Mallard et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  63. Early detection of skeletal muscle bioenergetic deficit by magnetic resonance spectroscopy in cigarette smoke-exposed mice
    Sandra Pérez-Rial et al, 2020, PLOS ONE CrossRef
  64. Voluntary exercise prevents abnormal muscle mitochondrial morphology in cancer cachexia mice
    Yu Kitaoka et al, 2021, Physiological Reports CrossRef
  65. Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats
    Anna Salazar-Degracia et al, 2017, PeerJ CrossRef